𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C

✍ Scribed by Marianne Ziol; Adriana Handra-Luca; Adrien Kettaneh; Christos Christidis; Frédéric Mal; Farhad Kazemi; Victor de Lédinghen; Patrick Marcellin; Daniel Dhumeaux; Jean-Claude Trinchet; Michel Beaugrand


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
139 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive procedure with several limitations. A new, noninvasive medical device based on transient elastography has been designed to measure liver stiffness. The aim of this study was to investigate the use of liver stiffness measurement (LSM) in the evaluation of liver fibrosis in patients with chronic hepatitis C. We prospectively enrolled 327 patients with chronic hepatitis C in a multicenter study. Patients underwent LB and LSM. METAVIR liver fibrosis stages were assessed on biopsy specimens by 2 pathologists. LSM was performed by transient elastography. Efficiency of LSM and optimal cutoff values for fibrosis stage assessment were determined by a receiver-operating characteristics (ROC) curve analysis and cross-validated by the jack-knife method. LSM was well correlated with fibrosis stage (Kendall correlation coefficient: 0.55; P < .0001). The areas under ROC curves were 0.79 (95% CI, 0.73-0.84) for F > or =2, 0.91 (0.87-0.96) for F > or =3, and 0.97 (0.93-1) for F=4; for larger biopsies, these values were, respectively, 0.81, 0.95, and 0.99. Optimal stiffness cutoff values of 8.7 and 14.5 kPa showed F > or =2 and F=4, respectively. In conclusion, noninvasive assessment of liver stiffness with transient elastography appears as a reliable tool to detect significant fibrosis or cirrhosis in patients with chronic hepatitis C.


📜 SIMILAR VOLUMES


Simple blood tests as noninvasive marker
✍ Leonardo L. Schiavon; Janaína L. N. Schiavon; Roberto J. Carvalho Filho; Juliana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o

Test–retest repeatability of MR elastogr
✍ Norah J. Shire; Meng Yin; Jun Chen; Radha A. Railkar; Sabrina Fox-Bosetti; Steph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract ## Purpose: To conduct a rigorous evaluation of the repeatability of liver stiffness assessed by MR elastography (MRE) in healthy and hepatitis‐C‐infected subjects. ## Materials and Methods: A biopsy‐correlated repeatability study using four‐slice MRE was conducted in five healthy an

Prediction of significant fibrosis in HB
✍ Min-De Zeng; Lun-Gen Lu; Yi-Min Mao; De-Kai Qiu; Ji-Qiang Li; Mo-Bin Wan; Cheng- 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy

Accuracy of liver stiffness measurement
✍ Nathalie Ganne-Carrié; Marianne Ziol; Victor de Ledinghen; Catherine Douvin; Pat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

A proper diagnosis of cirrhosis is essential for the management of patients with chronic liver diseases. We assessed the accuracy of liver stiffness measurement by Fibroscan for the diagnosis of cirrhosis in 1,257 patients with chronic liver diseases of various causes enrolled in a prospective multi

Relationship of serum fibrosis markers w
✍ Robert J. Fontana; Zachary D. Goodman; Jules L. Dienstag; Herbert L. Bonkovsky; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

This study determined the utility of a panel of serum fibrosis markers along with routine laboratory tests in estimating the likelihood of histological cirrhosis in a cohort of prior nonresponders with chronic hepatitis C. The relationship between serum markers and quantitative hepatic collagen cont